Diagnostic Center | May 25, 2022
Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Subscribe To Our Newsletter & Stay Updated
